News Nature: "Sidewinder" tech a leap forward in DNA synthesis A new technology developed at Caltech represents a breakthrough in DNA synthesis, essentially allowing de novo sequence creation.
News MSD takes on Pfizer's Prevnar with new Capvaxive approval MSD has claimed new territory for pneumococcal vaccines after getting FDA approval for use of Capvaxive in vulnerable children aged two to 17.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
